<DOC>
	<DOCNO>NCT00584844</DOCNO>
	<brief_summary>This study design determine safety immunogenicity Live Francisella tularensis Vaccine</brief_summary>
	<brief_title>Safety Immunogenicity Study Live Francisella Tularensis Vaccine</brief_title>
	<detailed_description>Study Objectives : 1 . Continue collect safety data Live NDBR 101 , Lot 4 Tularemia Vaccine ( primary booster dos ) , 2 . Continue collect immunogenicity data Live NDBR 101 , Lot 4 Tularemia Vaccine , 3 . Provide potential protection personnel risk occupational exposure F. tularensis collect data incidence occupational tularemia infection ( subclinical clinical ) immunize personnel .</detailed_description>
	<mesh_term>Tularemia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 year old , active military duty , 17 year old Females childbearing potential must agree urine pregnancy test immediately vaccination ( Exception : documented hysterectomy &gt; 3 year menopause ) . The result must negative . Volunteers must agree become pregnant 3 month receipt vaccine . Subject must actively enrol SIP Subjects must consider risk exposure F. tularensis . Subjects must uptodate ( within 1 year ) medical history , physical examination , laboratory test chart medically clear participation investigator . Examinations test may repeat within 1 year discretion enrol physician . Volunteer must willing return followup visit day 1 , 2 , 7 , day 1216 , day 2835 , day 5684 ( need ) , visit serology , well annual visit enrol protocol . Volunteer must agree report Adverse Event may may associate administration test article least 28 day vaccination . All Serious Unexpected Adverse Events report duration volunteer 's participation study . Clinically significant abnormal lab result include evidence Hepatitis C* , Hepatitis B* carrier state , elevate liver function test ( 2X normal value discretion PI ) . Personal history immunodeficiency current treatment oral intravenous immunosuppressive medication . Confirmed HIV* infection . Any medical condition discretion PI . Antibiotic therapy 7 day vaccination . Females must pregnant lactating ( female must agree become pregnant 3 month vaccination ) . Any known allergy excipients vaccine Administration another live vaccine within 4 week inactivate vaccine ( generally ) within 7 day tularemia vaccination . Any unresolved adverse event result previous immunization .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Live Vaccine Strain ( LVS ) , Bacterial Infections , Ulceroglandular , Oculoglandular</keyword>
</DOC>